Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01395459 · ClinicalTrials.gov registry record · NA
A Sustainable Approach to Increasing Cancer Screening
A NA study, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- NA
- Development phase
- 13,675
- Enrollment target
NCT01395459: Completed NA study, sponsored by Harvard School of Public Health (HSPH).
NCT01395459 is a NA study that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 13,675 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (875% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01395459, a NA study, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- NA
- Development phase
- 13,675 participants
- Enrollment target
Study Summary
Parent study: A Coordinated Approach to Cancer and Health (CATCH), was designed to compare the efficacy of two intervention arms (described below) intended to increase breast, cervical, and colon cancer screening rates among patients served by community health centers. A central focus of CATCH is to evaluate sustainable strategies for maximizing cancer screening rates among populations facing significant cancer disparities. CATCH was conducted in partnership with the large health clinic in Massachusetts, which serves a largely Hispanic low income population. Focusing on the use of an Interactive Voice Response (IVR) telephone technology system, the study is examining the extent to which the IVR, when developed in a culturally sensitive and appropriate manner (focus groups will be conducted to inform the intervention), can improve breast, cervical and colon cancer screening rates compared to a control group. Furthermore, we plan to determine if pairing IVR with telephone calls from a prevention care coordinator (PCC) will result in higher screening rates (when compared to the IVR only group). We will determine the cost-effectiveness of IVR alone vs. IVR + PCC. Substudy: We conducted a substudy of the parent study, looking at a comparison of return rates of two colorectal cancer screening home test kits: Fecal Occult Bood Tests (gFOBTs) and Fecal Immunochemical Tests (FITs). As well we surveyed people who pick up one of these two types of tests to assess barriers and facilitators of returning the completed kit to the health center for assessment.
Primary Outcome
The primary outcome of interest is improvement of population-level screening and individual outcomes for 3 cancers (breast, cervical, and colorectal)of patients reached during the intervention.
Interventions
- BEHAVIORAL IVR only
- BEHAVIORAL IVR+PCC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,675 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-10 |
| Phase | NA |
What the finished NCT01395459 record still lists
NCT01395459 is an interventional study that assigns participants to a tested intervention. Its 13,675 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (875% higher).
The record links to 0 conditions, and to 2 interventions - of which IVR only is the first listed.
NCT01395459 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01395459 about?
NCT01395459 is a clinical study titled "A Sustainable Approach to Increasing Cancer Screening". Parent study: A Coordinated Approach to Cancer and Health (CATCH), was designed to compare the efficacy of two intervention arms (described below) intended to increase breast, cervical, and colon cancer screening rates among patients served by community health centers. A central focus of CATCH is t...
What is the current status of trial NCT01395459?
This trial is currently completed. It is a NA study. The enrollment target is 13,675 participants. The study started on 2008-09. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01395459?
The interventions under investigation include: IVR only (BEHAVIORAL), IVR+PCC (BEHAVIORAL).
Who is sponsoring clinical trial NCT01395459?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01395459's enrollment target sits among peer trials
13,675 13th of 2000 higher than 1,988 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT05991453 · 13,000 participants · NA
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
- NCT07177352 · 13,000 participants · Phase 3
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia